Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02337231 · ClinicalTrials.gov registry record · NA
Botanical Oils Study to Determine Genetic Differences in the Way Your Body Processes Fats in Edible Oils
A NA study of Genetic Differences of Lipid Metabolism/Healthy Subjects, sponsored by Wake Forest University Health Sciences.
- Completed
- Registry status
- NA
- Development phase
- 66
- Enrollment target
- 1
- Study location
NCT02337231 is a NA study of Genetic Differences of Lipid Metabolism/Healthy Subjects that has completed, run by Wake Forest University Health Sciences. The registered enrollment target is 66 participants. The trial reports 1 study location across 1 state.
The verdict
NCT02337231, a NA study of Genetic Differences of Lipid Metabolism/Healthy Subjects, has completed, sponsored by Wake Forest University Health Sciences.
- COMPLETED
- Registry status
- NA
- Development phase
- 66 participants
- Enrollment target
- 1
- Study location
Study Summary
A randomized, controlled, cross-over clinical trial of borage oil vs soybean oil to determine whether the metabolism and/or impact of medium chain-polyunsaturated fatty acids (MC-PUFAs) in botanical oil supplements are changed in relationship to specific genotypes in a SNP (rs174537) strongly associated with FADS1 activity and PUFA metabolism.
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT soybean oil and borage oil
Study Locations (1)
North Carolina
- Wake Forest Baptist Medical Center - Winston-Salem
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 66 participants |
| Start Date | 2014-06-24 |
| Est. Completion | 2015-12-15 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02337231
The ClinicalTrials.gov registry entry for NCT02337231 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 66 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Wake Forest University Health Sciences, which has 1,140 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Genetic Differences of Lipid Metabolism/Healthy Subjects appearing as the primary indexed condition, and to 1 intervention - of which soybean oil and borage oil is the first listed.
NCT02337231 reports 1 study location spanning 1 distinct geographic area - top geographies include North Carolina.
Frequently Asked Questions
What is clinical trial NCT02337231 about?
NCT02337231 is a clinical study titled "Botanical Oils Study to Determine Genetic Differences in the Way Your Body Processes Fats in Edible Oils". A randomized, controlled, cross-over clinical trial of borage oil vs soybean oil to determine whether the metabolism and/or impact of medium chain-polyunsaturated fatty acids (MC-PUFAs) in botanical oil supplements are changed in relationship to specific genotypes in a SNP (rs174537) strongly associ...
What is the current status of trial NCT02337231?
This trial is currently completed. It is a NA study. The enrollment target is 66 participants. The study started on 2014-06-24. Estimated completion is 2015-12-15.
What conditions does trial NCT02337231 study?
This clinical trial studies the following conditions: Genetic Differences of Lipid Metabolism/Healthy Subjects.
What interventions are being tested in trial NCT02337231?
The interventions under investigation include: soybean oil and borage oil (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT02337231?
This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02337231 being conducted?
This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.